Stockreport

Genetic Technologies Limited Announces Further Collaborative Research with The University of Melbourne to Broaden the Applicability of the BREVAGenplus® Breast Cancer Risk Assessment Test

Genetic Technologies Ltd - American Depositary Shares  (GENE) 
US:NASDAQ Investor Relations: gtgcorporate.com/investor-centre
PDF MELBOURNE, Australia, March 16, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq:GENE) (“Company”), a diversified molecular diagnostics company [Read more]